Primary tabs

News

LSTM researchers investigate whether polio labs can help tackle neglected tropical diseases

From: LSTM

Blood samples being taken from a mother and child from Bukoba Village, Uganda

Study shows persistent and increasing malaria parasites despite access to regular treatment in Uganda

From: LSTM

Health workers demonstrate bednets, Courtesy of Sven Torffin, WHO World Malaria Day 2017

Malaria research agenda stresses the need for innovation and integration

From: LSTM

LSTM's 118th Annual General Meeting

From: LSTM

LSTM’s Alistair Reid Venom Research Unit at the Natural History Museum

From: LSTM

LF patients

New combination therapy of registered re-purposed drugs dramatically shortens anti-Wolbachia therapy for lymphatic filariasis and onchocerciasis from weeks to days

From: LSTM

LSTM’s Athena Swan Bronze Award is renewed

From: LSTM

AWOL identifies novel chemotypes in the search for drugs to combat LF and onchocerciasis

From: LSTM

Snakebite envenoming

From: LSTM

Professor Janet Hemingway announces her intention to retire as Director of LSTM

From: LSTM

Research team at LSTM develop new ways to create and deliver medications for a wide range of immune-mediated neuropathies.

From: LSTM

LSTM at the Big Bang North West festival

From: LSTM

Global health diagnostics course attendees. Photo credited to the University of McGill.

A review of the McGill summer institute’s course in Global Health Diagnostics

New Publication: qRT-PCR assay for Chikungunya

MRC Confidence in Concept 2017: Awards announced

From: LSTM

Recipients of LSTM’s new Director’s Catalyst Fund announced

From: LSTM

LSTM’s A·WOL Consortium at Africa Oyé

From: LSTM

LSTM well represented at WL6

LSTM Seminar report: "Antimicrobial Resistance; it’s in you!"

From: LSTM

LSTM launches new Transposon Registry

From: LSTM

LSTM and partners develop molecule that could lead to first synthetic one-dose malaria treatment

From: LSTM

Evaluation of the FluoroType MTB test published in ERJ Open

LSTM faculties receive Athena SWAN Bronze Awards

From: LSTM

First molecular diagnostics for insecticide resistance in sandflies

From: LSTM

Photo from Left to right: Prof. Russell Stothard, Dr. Renata Candido and Prof. Tim St Pierre

Worms, Magnets and Diagnostics: Exploring new methods to diagnose egg-patent schistosomiasis

Liverpool drug discovery group generates a new series of inhibitors active against multi drug resistant (MDR) Mycobacterium tuberculosis via an MRC funded DPFS award (Biagini PI)

Our recent activities by LSTM people in the field of NTDs

From: LSTM

Medical Research Council Proximity to Discovery Fund

Credit: Alex Ribeiro

LSTM led study examines the venom system of a tiny fish with big teeth

From: LSTM

Statement from LSTM following the UK's formal announcement to leave the EU

From: LSTM

RCDD reports on a new way of screening potential treatments for tuberculosis

From: LSTM

Cross section filarial nematode wolbachia in green

New anti-Wolbachia drug regimen could reduce treatment times of lymphatic filariasis and onchocerciasis to 1-2 weeks

From: LSTM

MRC Confidence in Concept Fund 2016-2017 Now open for applications

From: LSTM

Noguchi Polio Trip

IVCC secure licence with Indian manufacturer for production of IQKs developed at LSTM

From: LSTM

Centre of Excellence in Infectious Diseases Research launched

From: LSTM

LSTM project receives a special mention in Access to Medicines Index 2016

From: LSTM

LSTM’s 117th Annual General Meeting

From: LSTM

Seminar Series Report: Systematic reviews of diagnostic test accuracy in infectious diseases.

From: LSTM

Seminar report: Mechanistic understanding to enable multi-targeting anti-infectives.

From: LSTM

Pages